|
US2019263933A1
|
|
Activation of (na++k+)-atpase inhibits platelet aggregation and prevents thrombosis
|
|
US2019345260A1
|
|
Prevention and treatment of type-1 diabetes using agonists of the (na++k+)-atpase
|
|
US2017106062A1
|
|
Methods of inhibiting platelet aggregation and preventing thrombosis using antibodies that bind (Na++K+)-ATPase beta subunit
|
|
US2016355607A1
|
|
Activation of (NA++K+)-ATPase inhibits platelet aggregation and prevents thrombosis
|
|
US2015259438A1
|
|
Methods of inhibiting platelet aggregation and preventing thrombosis using antibodies that bind (Na++K+)-ATPase β subunit
|
|
US2015175709A1
|
|
Inotropic antibodies and therapeutic uses thereof
|
|
US2013310542A1
|
|
Inotropic Effects of Antibodies on Cardiac Contraction
|
|
US2013344566A1
|
|
Inotropic antibodies and therapeutic uses thereof
|
|
US2012020956A1
|
|
Antibodies that bind alpha subunit of sodium potassium ATPase
|
